Abbott wraps up $310M buyout of IDEV Technologies

08/26/2013 | MassDevice.com (Boston)

Abbott has completed its purchase of IDEV Technologies for $310 million. The acquisition includes IDEV's Supera Veritas system, a self-expanding stent designed to treat patients with peripheral artery disease. The device already is available commercially in Europe, but is still undergoing FDA premarket review.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care